
Tilray is a drug manufacturers-specialty & generic business based in the US. Tilray shares (TLRY) are listed on the NASDAQ and all prices are listed in US Dollars. Tilray employs 1,750 staff and has a trailing 12-month revenue of around $602.5 million.
How to buy Tilray stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – TLRY. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Tilray stock price (NASDAQ: TLRY)
Use our graph to track the performance of TLRY stocks over time.Tilray shares at a glance
Latest market close | $3.14 |
---|---|
52-week range | $2.52 - $9.08 |
50-day moving average | $3.32 |
200-day moving average | $3.71 |
Wall St. target price | $4.38 |
PE ratio | 7.7143 |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $0.42 |
Buy Tilray stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Tilray stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Tilray price performance over time
Historical closes compared with the close of $3.14 from 2023-02-07
1 week (2023-02-01) | -5.71% |
---|---|
1 month (2023-01-06) | 6.44% |
3 months (2022-11-08) | -17.37% |
6 months (2022-08-08) | -26.98% |
1 year (2022-02-04) | -47.23% |
---|---|
2 years (2021-02-08) | -89.56% |
3 years (2020-02-07) | 16.915 |
5 years (2018-02-04) | N/A |
Is Tilray stock undervalued or overvalued?
Valuing Tilray stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tilray's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tilray's P/E ratio
Tilray's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Tilray shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Tilray financials
Revenue TTM | $602.5 million |
---|---|
Gross profit TTM | $116.8 million |
Return on assets TTM | -2.38% |
Return on equity TTM | -11.9% |
Profit margin | -95.91% |
Book value | $7.29 |
Market capitalisation | $2 billion |
TTM: trailing 12 months
Tilray share dividends
We're not expecting Tilray to pay a dividend over the next 12 months.
Have Tilray's shares ever split?
Tilray's shares were split on 2 May 2021. This wouldn't directly have changed the overall worth of your Tilray shares – just the quantity. However, indirectly, the new INF% higher share price could have impacted the market appetite for Tilray shares which in turn could have impacted Tilray's share price.
Tilray share price volatility
Over the last 12 months, Tilray's shares have ranged in value from as little as $2.52 up to $9.08. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tilray's is 2.6198. This would suggest that Tilray's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Tilray overview
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc.
Tilray in the news
Why Tilray Brands Stock Stormed Higher in January
11 Best CBD Stocks To Buy Now
Tilray Brands Stock: Bear vs. Bull
Frequently asked questions
What percentage of Tilray is owned by insiders or institutions?Currently 1.59% of Tilray shares are held by insiders and 12.749% by institutions. How many people work for Tilray?
Latest data suggests 1,750 work at Tilray. When does the fiscal year end for Tilray?
Tilray's fiscal year ends in December. Where is Tilray based?
Tilray's address is: 265 Talbot Street West, Leamington, ON, Canada, N8H 5L4 What is Tilray's ISIN number?
Tilray's international securities identification number is: US88688T1007 What is Tilray's CUSIP number?
Tilray's Committee on Uniform Securities Identification Procedures number is: 88688T100
More guides on Finder
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert